Clinical Trial Update: Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery [Phase 1]

View source ↗

Summary

Phase I study of NouvNeu001 injection for moderate-to-advanced Parkinson's disease in patients who have previously undergone deep brain stimulation or lesioning…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NouvNeu001 Injection

Snippet

Sponsor: iRegene Therapeutics Co., Ltd. | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: NOT_YET_RECRUITING